| Literature DB >> 19783330 |
Lucilene Rezende Anastácio1, Agnaldo Soares Lima, Maria Isabel Toulson Davisson Correia.
Abstract
Metabolic syndrome is defined as the mutual existence of obesity, impaired fasting glucose levels, insulin resistance, hypertension, and dyslipidemia. After liver transplantation, patients typically develop these disorders, and even though there has been minimal research focused on the chronic impact of this syndrome on post-liver transplant patients, studies point to an association with major vascular events and fibrosis. The aim of the current work is to review data on the incidence, prevalence, risk factors, and implications of metabolic syndrome and its components in patients who have undergone liver transplantation. Copyright 2009 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19783330 DOI: 10.1016/j.clnu.2009.08.008
Source DB: PubMed Journal: Clin Nutr ISSN: 0261-5614 Impact factor: 7.324